Guest Editors
Assist. Prof. Hiroaki Iwamoto
Email: hiroaki017@yahoo.co.jp
Affiliation: Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
Homepage:
Research Interests: prostate cancer, bladder cancer, renal cell cancer
Summary
The landscape of oncology is rapidly evolving, driven by breakthroughs in molecular biology, immunology, and computational medicine. This Special Issue, titled "Emerging Frontiers and Multidisciplinary Approaches in Oncology: From Basic Science to Clinical Translation," aims to provide a comprehensive platform for disseminating high-quality research that spans the entire cancer continuum. This Special Issue welcomes contributions from both basic and clinical research fields.
We invite authors to submit original research articles, comprehensive reviews, and short communications that address critical challenges in cancer biology, diagnostics, and therapeutics. The scope of this issue is intentionally broad to foster cross-disciplinary dialogue. We particularly welcome studies focusing on, but not limited to: novel cancer biomarkers, the mechanisms of tumor microenvironment and metastasis, advancements in immunotherapy and targeted therapies, and the application of precision medicine in clinical settings. Furthermore, research integrating artificial intelligence, genomics, and innovative drug delivery systems is highly encouraged.
By bridging the gap between laboratory discoveries and clinical applications, this Special Issue seeks to showcase the latest innovations that improve patient outcomes and push the boundaries of current oncological knowledge. We look forward to receiving your impactful contributions to this diverse and fast-paced field.
Keywords
cancer biology, precision oncology, immunotherapy, targeted therapy, biomarkers, translational research, tumor microenvironment, clinical oncology, molecular diagnostics, cancer genetics
Login
Register
Submit a Paper
Propose a Special lssue